News + Font Resize -

Vanda Pharma receives Israeli marketing nod for Fanapt to treat schizophrenia
Washington | Friday, August 10, 2012, 16:30 Hrs  [IST]

The Israeli Ministry of Health (MoH) has granted marketing  approval for Vanda Pharmaceuticals' Fanapt for the treatment of schizophrenia.  

Vanda will commercialize Fanapt in Israel through its partner Megapharm Ltd., a leading private biotech, pharmaceutical and medical nutrition marketing companies in Israel.

Fanapt tablets are indicated for the treatment of adults with schizophrenia.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.

Post Your Comment

 

Enquiry Form